Tippingpoint Biosciences

Developer of therapeutics for treating diseases caused by dysfunctional genome chromatin packaging

placeSan Francisco, California, United States calendar_todayFounded 2022 language tippingpointbiosciences.com

Social engagement

Social engagement: 1.2K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include SOSV.

Investor typeCountShare
Venture capital563%
Angel & family office113%
Other / undisclosed225%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

9 Jan 2026 · Research Associate

Based on job postings tracked across public sources.

Recent activity

9 Jun 2026
Partnership
Freeflow
16 Jul 2025
Event
2025 Silicon Valley Cancer Technology Conference
Coming soon